Navigation Links
AHRQ Releases Consumer Financial Incentives Guide for Employers and Other Health Care Purchasers
Date:1/15/2008

ROCKVILLE, Md., Jan. 15 /PRNewswire-USNewswire/ -- HHS' Agency for Healthcare Research and Quality today announced a new guide to help employers, private health plans, the federal government, and state Medicaid agencies as they consider consumer financial incentives as part of an overarching strategy to improve the quality of health care and get better value for what they spend on services.

Consumer financial incentives are either a reward offered to influence patients to behave in a particular way, or, less often, a penalty for failing to do so. By using financial incentives, health care purchasers hope to encourage patients to take actions that either may improve the results of their treatment -- such as selecting a high-quality physician, reducing or eliminating high-risk behaviors and using preventive services -- or may reduce costs by eliminating unnecessary emergency room visits and decreasing preventable hospitalizations.

"Because health care spending is growing much faster than improvements in quality or patient safety, we must find ways to achieve better value for our health care dollars," said AHRQ Director Carolyn M. Clancy, M.D. "To help reach that goal, AHRQ is supporting a number of initiatives, including new resources for purchasers exploring the use of consumer financial incentives."

Using incentives to promote better value in health care is one of the four cornerstones of HHS' Value-Driven Care Initiative, which has a goal of providing consumers with the information necessary, and the incentive, to choose health care providers based on value.

The decision guide was developed by a team of researchers led by R. Adams Dudley, M.D., M.B.A., an associate professor with the Institute for Health Policy Studies at the University of California, San Francisco, in partnership with representatives of the purchaser and consumer communities.

Dr. Dudley said, "A number of strategies to improve quality --
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NHCAA Releases Fraud Fighters Handbook Outlining Strategies to Protect the Public Against Health Care Fraud
2. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
3. Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver
4. T.G.I. Fridays(R) Restaurants Releases 2008 Food-Related Resolutions Survey Results
5. AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission Decisions
6. Dallas-Fort Worth Business Group on Health Releases Report on the State of Diabetes in Texas
7. National Business Coalition on Health Releases 2008 eValue8(TM) RFI
8. EpiCept Releases New Data Demonstrating Prolonged Five-Year Leukemia-Free Survival for AML Patients Treated with Ceplene(TM) + IL-2
9. AHRQ Releases Toolkits to Help Providers and Patients Implement Safer Health Care Practices
10. AVOS Life Sciences Releases Diabetes Research Report
11. Siemens Releases New Version of INVISION to Aid Customers in Streamlining Clinical Workflow and Improving Quality of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
... between Hewlett Packard and the government in Nor...r prescriptions towards the implementation// of an...lth Social Services and Public Safety has announce...ern Ireland will be equipped with an electronic sy...
...ll have a new medical college from the next academ...ednesday that the proposed medical college will be...n addition to the new campus of the Rajiv Gandhi U... said, "The revenue department will identify alter...
...has revealed that those who drink coffee very rare...heavy drinkers.// According to a study in the Sep...ple could get a heart attack within one hour of ha...k of almost 60% amongst moderate coffee drinkers, ...
..."Pascal" Norris, who died in July, is thought to b...an two decades in Scotland. NHS Borders revealed t...ied on 8 July in Edinburgh Royal Infirmary and lat...died of anthrax. Health Protection Scotland said ...
Other Medicine News:
(Date:7/23/2008)... Protein Therapeutics that Modulate Alte...Mass., July 23 /- Taligen Therapeutic...e growth plan with the,appointment of Abbie Celnik...blishment of its headquarters in Cambridge, Mass. ...ounder of the company who remains president., Und...
(Date:7/22/2008)...ent Initiative bring MJFF,s,current active industr...2009, NEW YORK, July 22 /PRNewswire-USNewswire/ -...sformative treatments and a cure for Parkinson,s,d...n,s Research has awarded,$2.7 million in total fun...re granted under MJFF,s Therapeutics Development I...
(Date:7/22/2008)...a(R) Resulted in Significant, Reductions in A1C in...ithm Used, BRIDG... the "Adjust to,Target in Type 2 Diabetes: Compari... for Adjustment of Mealtime Insulin Glulisine" stu...ation,s (ADA) medical journal,Diabetes Care. This...
(Date:7/22/2008)...ersity Medical Center Based on Rosetta G...st Differentiates Squamous From Non-Squamous Non-S...us-Cell Carcinoma of the Lung With Sensitiv...is is the First CLIA Approved Test Which Leverages... Accurate Diagnosis of Lung Cancer, REHOVOT, Isra...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Hip replacement improves function saves money at any age 21969 1Hip replacement improves function saves money at any age 21969 2LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 1LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 2Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 1Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 2Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 1Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 2
... patients taking,once-daily Lialda remained relaps...May 22, 2007 /PRNewswire-FirstCall/ -- A,long-term... (303),presented at the British Society of Gastroe...rch 2007 showed Shire plc,s,Lialda(mesalamine) is ...day, secondary endpoints of study 303 were present...
... Doses, According to,New Data Presented at Digesti...wswire/ -- UCB announced today that,new data prese...ated long-term response and remission in Crohn,s d...pegol), the only Fc-free,PEGylated, Fab, fragment ... long-term open label,continuation of the Phase II...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
Delicate curved shafts with light crisscross serrations. Serrated handle with polished finish. Most popular size or model.
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Straight tubular shaft with delicate 1.5 mm oval jaws. Squeeze barrel style handle with tip guard and polished finish.
Medicine Products: